Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 3Breast Neoplasms 3Motor Activity 2Leiomyoma 2Warts 1Stomach Neoplasms 1Psychological Well-Being 1Psoriasis 1Prostatic Neoplasms 1Osteoporosis 1Osteoarthritis 1Obesity 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Inflammation 1Helicobacter Infections 1Esophageal Neoplasms 1Colorectal Neoplasms 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Autoimmune Diseases 1Arthritis, Rheumatoid 1

Interventions

Vitamin D 1Therapeutics 1Proton Pump Inhibitors 1Probiotics 1Observation 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Helicobacter Infections × Vitamin D × 1 year × Clear all
NCT07293910 2026-02-13

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Tanta University

Phase 2 Recruiting
66 enrolled

Helicobacter Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡